国药现代
(600420)
| 流通市值：116.15亿 | | | 总市值：116.15亿 |
| 流通股本：13.41亿 | | | 总股本：13.41亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,940,089,215.23 | 2,064,308,731.95 | 9,363,074,210.11 | 6,920,393,170.38 |
| 营业收入 | 3,940,089,215.23 | 2,064,308,731.95 | 9,363,074,210.11 | 6,920,393,170.38 |
| 二、营业总成本 | 3,563,631,034 | 1,831,280,671.98 | 8,138,476,387.82 | 5,860,075,336.79 |
| 营业成本 | 2,773,637,300.13 | 1,440,916,754.47 | 6,327,073,047.39 | 4,616,387,318.32 |
| 税金及附加 | 46,068,334.68 | 25,342,173.83 | 114,581,885.34 | 70,315,957.43 |
| 销售费用 | 229,905,166.33 | 120,808,052.67 | 530,429,479.49 | 354,815,378.47 |
| 管理费用 | 329,684,774 | 157,659,589.15 | 763,780,746.49 | 526,067,125.61 |
| 研发费用 | 168,421,837.7 | 78,818,875.25 | 441,787,180.31 | 331,629,773.76 |
| 财务费用 | 15,913,621.16 | 7,735,226.61 | -39,175,951.2 | -39,140,216.8 |
| 其中:利息费用 | 1,029,163.5 | 538,226.71 | 4,385,554 | 4,161,997.52 |
| 其中:利息收入 | 10,219,577.13 | 5,171,209.84 | 43,587,379.17 | 36,651,645.15 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 48,798,945.94 | 29,345,461.6 | 133,898,891.94 | 68,287,525.45 |
| 资产处置收益 | -557,240.54 | -71,247.36 | -2,651,461.17 | -741,783.88 |
| 资产减值损失(新) | -24,745,696.97 | -10,861,119.9 | -124,085,889.98 | -58,835,473.22 |
| 信用减值损失(新) | -8,636,108.75 | -8,814,861.23 | -15,665,563.81 | -16,983,348.29 |
| 其他收益 | 60,033,727.51 | 16,728,204.52 | 97,421,082.25 | 51,659,244 |
| 四、营业利润 | 451,351,808.42 | 259,354,497.6 | 1,313,514,881.52 | 1,103,703,997.65 |
| 加:营业外收入 | 4,726,970.54 | 1,088,023.45 | 35,968,925.55 | 29,951,908.93 |
| 减:营业外支出 | 12,982,455.83 | 12,123,325.24 | 21,898,768.83 | 18,166,847.34 |
| 五、利润总额 | 443,096,323.13 | 248,319,195.81 | 1,327,585,038.24 | 1,115,489,059.24 |
| 减:所得税费用 | 79,872,260.73 | 56,179,842.02 | 185,419,414.98 | 182,260,157.23 |
| 六、净利润 | 363,224,062.4 | 192,139,353.79 | 1,142,165,623.26 | 933,228,902.01 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 363,224,062.4 | 192,139,353.79 | 1,142,165,623.26 | 933,228,902.01 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 275,585,057.48 | 138,398,706.21 | 941,601,686.09 | 801,171,565.94 |
| 少数股东损益 | 87,639,004.92 | 53,740,647.58 | 200,563,937.17 | 132,057,336.07 |
| 扣除非经常损益后的净利润 | 255,792,242.6 | 145,925,074.51 | 849,182,430.15 | 739,392,587.5 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.21 | 0.1 | 0.7 | 0.6 |
| (二)稀释每股收益 | 0.21 | 0.1 | 0.7 | 0.6 |
| 八、其他综合收益 | -49,579.45 | - | -197,049.56 | -290,964.78 |
| 归属于母公司股东的其他综合收益 | -49,579.45 | - | -197,049.56 | -290,964.78 |
| 九、综合收益总额 | 363,174,482.95 | 192,139,353.79 | 1,141,968,573.7 | 932,937,937.23 |
| 归属于母公司股东的综合收益总额 | 275,535,478.03 | 138,398,706.21 | 941,404,636.53 | 800,880,601.16 |
| 归属于少数股东的综合收益总额 | 87,639,004.92 | 53,740,647.58 | 200,563,937.17 | 132,057,336.07 |
| 公告日期 | 2026-08-27 | 2026-04-30 | 2026-03-28 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |